Thailand’s AstraZeneca plan stumbles again as third wave rises

13 Sept 11:05 Key points summarised by AI

Thailand's primary COVID-19 vaccination strategy, heavily reliant on AstraZeneca, faces severe setbacks and critical shortages, causing widespread public confusion amidst a surging third wave of infections.
Government assurances about millions of AstraZeneca doses for the June 7 mass vaccination rollout have faltered, leading to the suspension of the main booking platform, Mor Prom, and uncertainty surrounding existing appointments.
With only a fraction of the targeted AstraZeneca doses acquired, the Ministry of Public Health adjusted the second dose interval to 16 weeks to stretch limited supplies, while relying on imported Sinovac doses as a critical backup.
Despite the Public Health Minister's insistence that mass vaccinations will commence on June 7, a lack of transparency persists regarding actual vaccine availability and which brand recipients will ultimately receive.

Speculation growing over merger between Bhumjaithai and Kla Tham parties

Today 16:46 Key points summarised by AI

A dinner between Bhumjaithai and Kla Tham party leaders sparked rumors of a potential merger, though Bhumjaithai's leader, Anutin, downplayed it as a casual meal.
The meeting is widely interpreted as a strategic message from Bhumjaithai to the Pheu Thai party, signaling alternative support ahead of an upcoming no-confidence debate.
Thailand's Constitution (Section 99) currently prohibits direct mergers of parties with sitting MPs during the House's term, a rule designed to prevent the 'buying and selling' of MPs.
While direct mergers are restricted, MPs can still switch parties if dismissed by a three-fourths party vote or if their party dissolves, allowing for indirect political realignments.
Kla Tham's voting behavior in the censure debate will demonstrate its loyalty to the government, potentially influencing future political dynamics despite current merger restrictions.